Profound Medical Corp. PROF NASDAQ

Profound Medical Corp. (PROF) generated $-53.34M in operating cash flow for fiscal year 2025. After capital expenditures of $245.73K, free cash flow was $-53.59M.

Free cash flow margin was -327.2% of revenue. Cash conversion ratio was -1.26x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
• MOAT (50/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (100/100) — Cash conversion ratio was -1.26x suggests some earnings are non-cash items

Overall SharesGrow Score: 81/100 with 5/7 criteria passed.